Filtered By:
Vaccination: Cervical Cancer Vaccine

This page shows you your search results in order of relevance. This is page number 14.

Order by Relevance | Date

Total 852 results found since Jan 2013.

HPV strains affecting African-American women differ from vaccines
(Duke University Medical Center) Two subtypes of human papillomavirus prevented by vaccines are half as likely to be found in African-American women as in white women with precancerous cervical lesions, according to researchers at Duke Medicine.
Source: EurekAlert! - Social and Behavioral Science - October 28, 2013 Category: Global & Universal Source Type: news

Preliminary results find African-American women disadvantaged when it comes to HPV vaccines
Two subtypes of human papillomavirus (HPV) prevented by vaccines are half as likely to be found in African-American women as in white women with precancerous cervical lesions, according to researchers at Duke Medicine. The findings, presented at the 12th annual International Conference on Frontiers in Cancer Prevention Research hosted by the American Association for Cancer Research, suggest that African-American women may be less likely to benefit from available HPV vaccines to prevent cervical cancer. HPV is a common sexually transmitted infection with more than 40 subtypes...
Source: Health News from Medical News Today - October 30, 2013 Category: Consumer Health News Tags: Cervical Cancer / HPV Vaccine Source Type: news

1 dose of HPV vaccine may be enough to prevent cervical cancer
(American Association for Cancer Research) Women vaccinated with one dose of a human papillomavirus (HPV) vaccine had antibodies against the viruses that remained stable in their blood for four years, suggesting that a single dose of vaccine may be sufficient to generate long-term immune responses and protection against new HPV infections, and ultimately cervical cancer, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
Source: EurekAlert! - Medicine and Health - November 4, 2013 Category: Global & Universal Source Type: news

Updated Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children Released
The National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), the HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA), the Pediatric Infectious Disease Society (PIDS), and the American Academy of Pediatrics (AAP) announce the release of the updated Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children. The guidelines were simultaneously published in the Pediatric Infectious Disease Journal (PIDJ).   Selected key updates to the guidelines include the following: Greater emphasis on the importa...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 6, 2013 Category: Infectious Diseases Source Type: news

Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects
ConclusionsNo evidence of an increase in risk of the studied ADs was observable following vaccination with Gardasil within the time periods studied. There was insufficient statistical power to allow conclusions to be drawn regarding individual ADs.This article is protected by copyright. All rights reserved.
Source: Journal of Internal Medicine - November 8, 2013 Category: Internal Medicine Authors: Lamiae Grimaldi‐Bensouda, Didier Guillemot, Bertrand Godeau, Jacques Bénichou, Christine Lebrun‐Frenay, Caroline Papeix, Pierre Labauge, Patrick Berquin, Alfred Penfornis, Pierre‐Yves Benhamou, Marc Nicolino, Albane Simon, Jean‐François Viallard Tags: Original Source Type: research

Survey: Knowledge about HPV vaccine effectiveness lacking
(American Association for Cancer Research) Knowledge about the efficacy of the human papillomavirus (HPV) vaccine in preventing cervical cancer was lacking in the majority of survey respondents for whom the information would be relevant, according to results presented here at the Sixth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held Dec. 6-9.
Source: EurekAlert! - Medicine and Health - December 7, 2013 Category: Global & Universal Source Type: news

A shorter interval between menarche and first sexual intercourse is associated with increased risk of high-grade cervical disease
Commentary on: Ruiz AM, Ruiz JE, Gavilanes AV, et al.. for the FUTURE I and II Study Group. Proximity of first sexual intercourse to menarche and risk of high-grade cervical disease. J Infect Dis 2012;206:1887–96. Implications for practice and research Female adolescents with a shorter duration between the age of menarche and first sexual intercourse are at an increased risk of high-grade cervical disease. Clinical counselling should include clear recommendations to obtain human papillomavirus (HPV) vaccination well before first intercourse to reduce the future risk of high-grade cervical lesions among sexually na&i...
Source: Evidence-Based Nursing - December 10, 2013 Category: Nursing Authors: Smith, J. S. Tags: Sexual transmitted infections (bacterial), Immunology (including allergy), Drugs: infectious diseases, Vaccination / immunisation, Cervical cancer, Contraception, Drugs: obstetrics and gynaecology, Reproductive medicine, Gynecological cancer, Ophthalmolog Source Type: research

One Lot of HPV Vaccine Gardasil RecalledOne Lot of HPV Vaccine Gardasil Recalled
A small number of vials of Gardasil in lot number J007354 may contain glass particles in what federal health officials call an 'isolated' manufacturing incident. News Alerts
Source: Medscape Today Headlines - December 23, 2013 Category: Consumer Health News Tags: Family Medicine/Primary Care News Alert Source Type: news

Prevalence of high‐risk human papillomavirus type 16 and 18 in oral and cervical cancers in population from Gujarat, West India
ConclusionThe results suggested that HPV 16 and 18 do not play an important role in oral carcinogenesis in the population from Gujarat, West India. However, HPV 16 is highly prevalent in the cervical cancer patients, which may be considered for planning of prevention programs such as screening and vaccination in women from this region.
Source: Journal of Oral Pathology and Medicine - November 1, 2013 Category: Pathology Authors: Kinjal R. Patel, Bhairavi N. Vajaria, Rasheedunnisa Begum, Ava Desai, Jayendra B. Patel, Franky D. Shah, Shilin N. Shukla, Prabhudas S. Patel Tags: Original Article Source Type: research

South Africa: Schoolgirls to Get Cancer Immunisation
[SAPA]Johannesburg -Primary school girls would be immunised this year against the Human Papilloma Virus (HPV) that causes cervical cancer, President Jacob Zuma said on Thursday.
Source: AllAfrica News: Health and Medicine - January 17, 2014 Category: African Health Source Type: news

Zimbabwe: Cancer Vaccines for Young Girls Roll Out
[The Herald]Government will start distributing the first consignment of the Human Papilloma Virus (HPV) vaccine to young girls by end of March to combat cervical cancer. Speaking after a tour of the central vaccines' stores at Parirenyatwa Group of OF Hospitals on Tuesday, director of Epidemiology and Diseases Control in the Ministry of Health and Child Care Dr Portia Manangazira said the vaccine would be given to girls before they are sexually active.
Source: AllAfrica News: Health and Medicine - January 17, 2014 Category: African Health Source Type: news

Role of developing countries vaccine manufacturers towards global health care by proving quality vaccines at affordable prices
This article is protected by copyright. All rights reserved.
Source: Clinical Microbiology and Infection - January 29, 2014 Category: Microbiology Authors: Suresh Jadhav, Manish Gautam, Sunil Gairola Tags: Supplement Article Source Type: research

Protein serves as a natural boost for immune system fight against tumors
(University of Pennsylvania School of Medicine) Different molecular adjuvants, such as cytokines, are being studied as a way to increase the efficacy of vaccines. The development of DNA-based vaccines with cytokine adjuvants has emerged as particularly promising for inducing antiviral and anti-tumor, cell-mediated immune responses. The protein IL-33 boosts the immune system of a human papilloma virus animal model of cancer.
Source: EurekAlert! - Cancer - January 30, 2014 Category: Cancer & Oncology Source Type: news

20% rise in penile cancer: are STIs to blame?
Conclusion This study found that the incidence of penile cancer increased by 20% from 1979 to 2009; however, it fluctuated during the period. For example, the incidence in 2008 was the same as in 1980, although the overall trend is that of an increase. The study does not prove the causes of this increase, but the most important factors known to increase the risk include: smoking human papilloma virus (which causes warts) However, it is also possible that the increased incidence of penile cancer is due simply to more people being diagnosed. The apparent good news is that the proportion of men surviving for at least a yea...
Source: NHS News Feed - February 19, 2014 Category: Consumer Health News Tags: Cancer Source Type: news

Namibia: Govt to Roll Out Cervical Cancer Vaccine
[New Era]Windhoek -Government will roll out cervical cancer vaccine, or human papillomavirus vaccine, at public health facilities as cervical cancer is identified as the second most common cancer after breast cancer among Namibian women. Medical doctors and health practicitioners have welcomed the plans saying it would improve health access to poor people, as currently the vaccine is only available at private health facilities.
Source: AllAfrica News: Health and Medicine - February 28, 2014 Category: African Health Source Type: news